Annual Operating Expenses
$82.20 M
-$41.28 M-33.43%
December 31, 2023
Summary
- As of February 22, 2025, PYXS annual total operating expenses is $82.20 million, with the most recent change of -$41.28 million (-33.43%) on December 31, 2023.
- During the last 3 years, PYXS annual operating expenses has risen by +$69.30 million (+537.47%).
- PYXS annual operating expenses is now -33.43% below its all-time high of $123.48 million, reached on December 31, 2022.
Performance
PYXS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$23.75 M
+$3.72 M+18.58%
September 30, 2024
Summary
- As of February 22, 2025, PYXS quarterly total operating expenses is $23.75 million, with the most recent change of +$3.72 million (+18.58%) on September 30, 2024.
- Over the past year, PYXS quarterly operating expenses has dropped by -$1.60 million (-6.31%).
- PYXS quarterly operating expenses is now -37.45% below its all-time high of $37.97 million, reached on December 31, 2022.
Performance
PYXS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PYXS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.4% | -6.3% |
| 3 y3 years | +537.5% | +31.1% |
| 5 y5 years | +2755.0% | +31.1% |
PYXS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.4% | +17.9% | -37.5% | +44.6% |
| 5 y | 5-year | -33.4% | +2755.0% | -37.5% | +644.2% |
| alltime | all time | -33.4% | +2755.0% | -37.5% | +644.2% |
Pyxis Oncology Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.75 M(+18.6%) |
| Jun 2024 | - | $20.03 M(-5.8%) |
| Mar 2024 | - | $21.28 M(+19.8%) |
| Dec 2023 | $82.20 M(-33.4%) | $17.77 M(-29.9%) |
| Sep 2023 | - | $25.35 M(+39.9%) |
| Jun 2023 | - | $18.12 M(-13.5%) |
| Mar 2023 | - | $20.95 M(-44.8%) |
| Dec 2022 | $123.48 M | $37.97 M(+33.7%) |
| Sep 2022 | - | $28.39 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $25.73 M(-18.0%) |
| Mar 2022 | - | $31.39 M(+91.1%) |
| Dec 2021 | $69.72 M(+440.7%) | $16.43 M(+41.3%) |
| Sep 2021 | - | $11.62 M(+95.6%) |
| Jun 2021 | - | $5.94 M(-83.4%) |
| Mar 2021 | - | $35.73 M(+680.3%) |
| Dec 2020 | $12.89 M(+347.9%) | $4.58 M(+43.5%) |
| Sep 2020 | - | $3.19 M |
| Dec 2019 | $2.88 M | - |
FAQ
- What is Pyxis Oncology annual total operating expenses?
- What is the all time high annual operating expenses for Pyxis Oncology?
- What is Pyxis Oncology annual operating expenses year-on-year change?
- What is Pyxis Oncology quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pyxis Oncology?
- What is Pyxis Oncology quarterly operating expenses year-on-year change?
What is Pyxis Oncology annual total operating expenses?
The current annual operating expenses of PYXS is $82.20 M
What is the all time high annual operating expenses for Pyxis Oncology?
Pyxis Oncology all-time high annual total operating expenses is $123.48 M
What is Pyxis Oncology annual operating expenses year-on-year change?
Over the past year, PYXS annual total operating expenses has changed by -$41.28 M (-33.43%)
What is Pyxis Oncology quarterly total operating expenses?
The current quarterly operating expenses of PYXS is $23.75 M
What is the all time high quarterly operating expenses for Pyxis Oncology?
Pyxis Oncology all-time high quarterly total operating expenses is $37.97 M
What is Pyxis Oncology quarterly operating expenses year-on-year change?
Over the past year, PYXS quarterly total operating expenses has changed by -$1.60 M (-6.31%)